Alliance for Genomic Discovery Archive — Page 1 of 1

August 12, 2026

Alexander Bick to lead cutting-edge resource for genomic discovery at Vanderbilt Health

Vanderbilt Technologies for Advanced Genomics is a one-stop genomics research resource that offers sample biobanking, genome sequencing, single-cell and spatial multiomic profiling, and other specialized services.

By Bill Snyder

March 5, 2026

Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering

Dataset grows to more than 312,000 whole genomes with longitudinal clinical data. GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data.

June 23, 2025

Low blood cell counts drive cancer in explosive blood disorder: study

The analysis of genetic sequencing data from more than 34,000 people over a 17-year period by researchers at VUMC was published in eClinicalMedicine.

By Bill Snyder

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.

March 19, 2025

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

The milestone creates one of the largest, most comprehensive clinical genomic datasets of its kind; multiomic data to be added in next phase of program.

By Vanderbilt Health News

January 5, 2024

The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK and Novo Nordisk

Bristol Myers Squibb, GSK and Novo Nordisk are the newest members of the Alliance for Genomic Discovery.

July 18, 2023

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck

Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.